Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT
Quince Therapeutics Fail-to-Deliver
Total FTD Shares
5.76K
Below Average
FTD / Avg. Volume
2.22%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 10, 2025,
Quince Therapeutics Inc. has
5,765
shares failed to deliver, representing 2.22%
of the average daily volume of
259,522
shares. Over the past year, the monthly average FTD is
13,408
shares, with the current level 57% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 10, 2025 | 1.78 | 5.76K | -88.18% |
Jun 26, 2025 | 1.5 | 48.79K | +1.51% |
May 21, 2025 | 1.03 | 48.06K | +49450.52% |
Apr 21, 2025 | 1.05 | 97 | -14.16% |
Mar 17, 2025 | 1.38 | 113 | -89.63% |
Feb 27, 2025 | 1.39 | 1.09K | -47.22% |
Jan 28, 2025 | 1.6 | 2.06K | +374.71% |
Dec 31, 2024 | 1.87 | 435 | -70.77% |
Nov 27, 2024 | 2.04 | 1.49K | +9.01% |
Oct 30, 2024 | 1.31 | 1.36K | -34.88% |
Sep 30, 2024 | 0.7762 | 2.1K | -91.92% |
Aug 30, 2024 | 0.691 | 25.95K | +6019.81% |
Jul 31, 2024 | 0.7499 | 424 | -87.76% |
Jun 11, 2024 | 0.788 | 3.46K | +617.39% |
May 30, 2024 | 0.8323 | 483 | -88.71% |
Apr 26, 2024 | 1.06 | 4.28K | +4501.08% |
Mar 28, 2024 | 1.06 | 93 | -88.66% |
Feb 29, 2024 | 1.3 | 820 | -97.43% |
Jan 31, 2024 | 1.24 | 31.93K | +446.20% |
Dec 29, 2023 | 1.05 | 5.85K | +1256.38% |
Nov 30, 2023 | 0.89 | 431 | -86.53% |
Oct 19, 2023 | 1.03 | 3.2K | -8.26% |
Sep 28, 2023 | 1.16 | 3.49K | -53.12% |
Aug 14, 2023 | 1.24 | 7.44K | +1127.89% |
Jul 31, 2023 | 1.2 | 606 | +84.76% |
Jun 30, 2023 | 1.51 | 328 | -32.79% |
May 31, 2023 | 1.5 | 488 | -84.38% |
Apr 28, 2023 | 1.53 | 3.12K | -85.05% |
Mar 31, 2023 | 1.56 | 20.89K | +0.52% |
Feb 28, 2023 | 0.9276 | 20.78K | -89.94% |
Jan 31, 2023 | 0.98 | 206.5K | n/a |